Welcome to LookChem.com Sign In|Join Free

CAS

  • or

109384-19-2

Post Buying Request

109384-19-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

109384-19-2 Usage

Chemical Properties

White to cream powder

Uses

Different sources of media describe the Uses of 109384-19-2 differently. You can refer to the following data:
1. N-Boc-4-hydroxypiperidine is a 4-hydroxypyridine with a boc protecting group used in the preparation of neurologically active agents and other pharmaceutical compounds.
2. Used in a synthesis of N-heterocyclic alkyl ethers via the Mitsunobu reaction.

Check Digit Verification of cas no

The CAS Registry Mumber 109384-19-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,3,8 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 109384-19:
(8*1)+(7*0)+(6*9)+(5*3)+(4*8)+(3*4)+(2*1)+(1*9)=132
132 % 10 = 2
So 109384-19-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H19NO3/c1-10(2,3)14-9(13)11-6-4-8(12)5-7-11/h8,12H,4-7H2,1-3H3

109384-19-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (495484)  1-Boc-4-hydroxypiperidine  97%

  • 109384-19-2

  • 495484-5G

  • 452.79CNY

  • Detail
  • Aldrich

  • (495484)  1-Boc-4-hydroxypiperidine  97%

  • 109384-19-2

  • 495484-25G

  • 1,490.58CNY

  • Detail

109384-19-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name N-BOC-4-Hydroxypiperidine

1.2 Other means of identification

Product number -
Other names 1-Boc-4-piperidinol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:109384-19-2 SDS

109384-19-2Synthetic route

4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With sodium hydroxide In water; tert-butyl alcohol at 20℃;100%
With sodium carbonate In dichloromethane; water for 72h;100%
With sodium carbonate In dichloromethane; water for 72h; Inert atmosphere;100%
N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With sodium tetrahydroborate In ethanol100%
Stage #1: N-tert-butyloxycarbonylpiperidin-4-one With sodium tetrahydroborate In ethanol at 0 - 20℃; for 4h;
Stage #2: With water; ammonium chloride In ethanol
100%
With sodium hydroxide; sodium borohydrid In methanol100%
4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With tert-butyldicarbonate; triethylamine In dichloromethane at 0℃; for 21h;100%
4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

tert-butyldicarbonate
34619-03-9

tert-butyldicarbonate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With sodium hydrogencarbonate In dichloromethane for 15h;100%
In tetrahydrofuran at 20℃;98.3%
With triethylamine In tetrahydrofuran at 20℃;98.3%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

piperidin-4-ol hydrochloride
5382-17-2

piperidin-4-ol hydrochloride

sodium hydrogencarbonate
144-55-8

sodium hydrogencarbonate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
In 1,4-dioxane100%
In 1,4-dioxane100%
pyridin-4-ol
626-64-2

pyridin-4-ol

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: pyridin-4-ol With chloro(1,5-cyclooctadiene)rhodium(I) dimer; borane-ammonia complex In 2,2,2-trifluoroethanol at 50℃; for 24h; Inert atmosphere; Schlenk technique; Sealed tube;
Stage #2: di-tert-butyl dicarbonate With triethylamine In 2,2,2-trifluoroethanol at 20℃; Inert atmosphere; Schlenk technique; Sealed tube;
99%
4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

carbon monoxide
201230-82-2

carbon monoxide

tert-butyl alcohol
75-65-0

tert-butyl alcohol

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With 2C7H9N4*Au(1+)*Cu(1+)*2I(1-) In toluene at 90℃; for 8h; Autoclave;98%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; ethyl acetate95%
Multi-step reaction with 2 steps
1: triethylamine / water; 1,4-dioxane / 0 - 20 °C
2: sodium tetrahydroborate; methanol / 0 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane / 0.8 h / 0 - 20 °C
2: sodium tetrahydroborate; methanol / 0.01 h / 0 - 20 °C
View Scheme
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

A

t-butyl piperidinecarboxylate
75844-69-8

t-butyl piperidinecarboxylate

B

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; ethyl acetateA n/a
B 94%
With triethylamine In tetrahydrofuran; ethyl acetateA n/a
B 94%
With triethylamine In tetrahydrofuran; ethyl acetateA n/a
B 94%
tert-butyl 4-((4-methoxybenzyl)oxy)piperidine-1-carboxylate
1311186-22-7

tert-butyl 4-((4-methoxybenzyl)oxy)piperidine-1-carboxylate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With N,N,N,N-tetraethylammonium tetrafluoroborate In methanol Electrochemical reaction;81%
t-butyl piperidinecarboxylate
75844-69-8

t-butyl piperidinecarboxylate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With D-glucose; cells of Sphingomonas sp. HXN-200 In phosphate buffer at 30℃; for 2h; pH=8.0;69.5%
4-[(1-{tert-butoxycarbonyl}-4-piperidinyl)oxy]-1-(1-methylethyl)pyridinium iodide
845305-79-5

4-[(1-{tert-butoxycarbonyl}-4-piperidinyl)oxy]-1-(1-methylethyl)pyridinium iodide

A

tert-butyl 4-{[1-(1-methylethyl)-4-piperidinyl]oxy}-1-piperidinecarboxylate
845305-80-8

tert-butyl 4-{[1-(1-methylethyl)-4-piperidinyl]oxy}-1-piperidinecarboxylate

B

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With platinum (IV) oxide; hydrogen In ethanol at 20℃; under 2587.76 Torr; for 144h;A 54%
B 20%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

piperidin-4-ol hydrochloride
5382-17-2

piperidin-4-ol hydrochloride

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With sodium hydroxide In water at 25℃; for 1h;
Methoxyallene
13169-00-1

Methoxyallene

N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

A

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

B

N-(tert-butoxycarbonyl)-4-[(Z)-3-methoxyprop-2-enyl]piperidin-4-ol

N-(tert-butoxycarbonyl)-4-[(Z)-3-methoxyprop-2-enyl]piperidin-4-ol

C

N-(tert-butoxycarbonyl)-4-[(E)-3-methoxyprop-2-enyl]piperidin-4-ol

N-(tert-butoxycarbonyl)-4-[(E)-3-methoxyprop-2-enyl]piperidin-4-ol

Conditions
ConditionsYield
With N,N,N,N,N,N-hexamethylphosphoric triamide; samarium diiodide; tert-butyl alcohol In tetrahydrofuran at 20℃; Title compound not separated from byproducts;
C13H18BrN3O2
950848-59-6

C13H18BrN3O2

N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

A

C23H35BrN4O4
950848-60-9

C23H35BrN4O4

B

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: C18H26BrN3O4 With trifluoroacetic acid In dichloromethane for 0.5h;
Stage #2: C13H18BrN3O2; N-tert-butyloxycarbonylpiperidin-4-one With sodium tris(acetoxy)borohydride; triethylamine In 1,2-dichloro-ethane at 20℃; for 16h;
Stage #3: With water; sodium hydrogencarbonate In dichloromethane; 1,2-dichloro-ethane
sodium potassium tartrate tetrahydrate

sodium potassium tartrate tetrahydrate

N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With diisobutylaluminium hydride In tetrahydrofuran; toluene
3-(1-tert-butoxycarbonylpiperidin-4-yloxy)benzoic acid
250681-69-7

3-(1-tert-butoxycarbonylpiperidin-4-yloxy)benzoic acid

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

titanium(IV) isopropylate
546-68-9

titanium(IV) isopropylate

N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

2-phenyl-3-keto-piperazine
5368-28-5

2-phenyl-3-keto-piperazine

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With sodium cyanoborohydride In methanol
4-[3-(N-BOC-Piperidin-4-yl)propyl]benzoic acid
163210-39-7

4-[3-(N-BOC-Piperidin-4-yl)propyl]benzoic acid

A

4-[3-(Piperidin-4-yl)propyl]benzoyl-2(S)-phenyl-sulfonylamino-β-alanine

4-[3-(Piperidin-4-yl)propyl]benzoyl-2(S)-phenyl-sulfonylamino-β-alanine

B

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

4-piperidone monohydrochloride monohydrate
40064-34-4

4-piperidone monohydrochloride monohydrate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With sodium borohydrid; N-ethyl-N,N-diisopropylamine In N-methyl-acetamide; ethanol; water
4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

3-(1-tert-butoxycarbonylpiperidin-4-yloxy)benzoic acid
250681-69-7

3-(1-tert-butoxycarbonylpiperidin-4-yloxy)benzoic acid

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With triethylamine In dichloromethane
4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

A

4-[(1H-benzimidazol-2-ylmethyl)-(5,6,7,8-tetrahydroquinolin-8-yl)-amino]-piperidine-1-carboxylic Acid Amide (Hydrobromide Salt)
558448-73-0

4-[(1H-benzimidazol-2-ylmethyl)-(5,6,7,8-tetrahydroquinolin-8-yl)-amino]-piperidine-1-carboxylic Acid Amide (Hydrobromide Salt)

B

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
In tetrahydrofuran
(R)-1-cyclohexyl-4-phenyl-3-(piperidin-4-yl)imidazolidin-2-one
926291-23-8

(R)-1-cyclohexyl-4-phenyl-3-(piperidin-4-yl)imidazolidin-2-one

N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

A

4-((R)-3-cyclohexyl-2-oxo-5-phenyl-imidazolidin-1-yl)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester
1032818-37-3

4-((R)-3-cyclohexyl-2-oxo-5-phenyl-imidazolidin-1-yl)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester

B

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With sodium cyanoborohydride; acetic acid In methanol at 60℃; for 16h;
4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

tert-butyl chloroformate
24608-52-4

tert-butyl chloroformate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With triethylamine
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

4-hydroxypiperazine
69395-49-9

4-hydroxypiperazine

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 5h;34 g
tert-butyl 4-(tosyloxy)piperidin-1-carboxylate
118811-07-7

tert-butyl 4-(tosyloxy)piperidin-1-carboxylate

C9H15ClMg
245507-96-4

C9H15ClMg

A

C19H33NO2

C19H33NO2

B

N-Boc-1,2,3,6-tetrahydropyridine
85838-94-4

N-Boc-1,2,3,6-tetrahydropyridine

C

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With dilithium tetrachlorocuprate In tetrahydrofuran at 40℃;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate
141699-59-4

1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate

C9H15ClMg
245507-96-4

C9H15ClMg

A

C19H33NO2

C19H33NO2

B

N-Boc-1,2,3,6-tetrahydropyridine
85838-94-4

N-Boc-1,2,3,6-tetrahydropyridine

C

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

Conditions
ConditionsYield
With copper dichloride In tetrahydrofuran at 20℃;
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-(tosyloxy)piperidin-1-carboxylate
118811-07-7

tert-butyl 4-(tosyloxy)piperidin-1-carboxylate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 20h;100%
at 20℃; for 20h;99%
With triethylamine In dichloromethane at 20℃;89%
methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate
141699-59-4

1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 5℃; for 3h;100%
With triethylamine In dichloromethane at 0 - 20℃; for 2.16667h;100%
With triethylamine In dichloromethane at 0 - 20℃; for 2.16667h;100%
acetic anhydride
108-24-7

acetic anhydride

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

2-methylpropan-2-yl 4-(acetyloxy)piperidine-1-carboxylate
850452-53-8

2-methylpropan-2-yl 4-(acetyloxy)piperidine-1-carboxylate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 5h;100%
With dmap; triethylamine In dichloromethane at 0 - 20℃;55.17%
In pyridine at 25℃; for 6h;
With pyridine at 20℃;3 g
With pyridine at 20℃; for 5h;3 g
2-fluorobenzonitrile
394-47-8

2-fluorobenzonitrile

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

4-(2-cyano-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester
647014-70-8

4-(2-cyano-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20 - 50℃;100%
With (E)-[4-(hydroxy)piperidin-1-ylsulphonyl]-2-(3-pyridyl)ethene In DMF (N,N-dimethyl-formamide) for 15h;
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 2h;
Stage #2: 2-fluorobenzonitrile at 50℃; for 1h;
1-chloroisoquinoline
19493-44-8

1-chloroisoquinoline

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

1-tert-butoxycarbonyl-4-(1-isoquinolinyloxy)-piperidine
817187-34-1

1-tert-butoxycarbonyl-4-(1-isoquinolinyloxy)-piperidine

Conditions
ConditionsYield
With crown ether; potassium tert-butylate In DMF (N,N-dimethyl-formamide) at 20℃;100%
salicylonitrile
611-20-1

salicylonitrile

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

2-(piperidin-4-yloxy)-benzonitrile hydrochloride

2-(piperidin-4-yloxy)-benzonitrile hydrochloride

Conditions
ConditionsYield
Stage #1: salicylonitrile; t-butyl 4-hydroxy piperidine-1-carboxylate With di-tert-butyl-diazodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 18h;
Stage #2: With hydrogenchloride; water In 1,4-dioxane at 20℃; for 18h;
100%
4-chlorpyridine hydrochloride
7379-35-3

4-chlorpyridine hydrochloride

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

2-(piperidin-4-yloxy)pyridine
127806-46-6

2-(piperidin-4-yloxy)pyridine

Conditions
ConditionsYield
In tetrahydrofuran; dimethyl sulfoxide100%
In tetrahydrofuran; dimethyl sulfoxide100%
In tetrahydrofuran; dimethyl sulfoxide100%
4-(4-chlorophenoxy)phenol
21567-18-0

4-(4-chlorophenoxy)phenol

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-[4-(4-chloro-phenoxy)-phenoxy]-piperidine-1-carboxylate

tert-butyl 4-[4-(4-chloro-phenoxy)-phenoxy]-piperidine-1-carboxylate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 47℃; for 65.1667h;100%
2-(4-hydroxyphenyl)-5-methyl-2H-pyrazole-3-carboxylic acid cyclohexylamide
946859-60-5

2-(4-hydroxyphenyl)-5-methyl-2H-pyrazole-3-carboxylic acid cyclohexylamide

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

4-[4-(5-cyclohexylcarbamoyl-3-methylpyrazol-1-yl)phenoxy]piperidine-1-carboxylic acid tert-butyl ester
946859-61-6

4-[4-(5-cyclohexylcarbamoyl-3-methylpyrazol-1-yl)phenoxy]piperidine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃;100%
2-chloropyrazin
14508-49-7

2-chloropyrazin

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

t-butyl 4-[(pyrazin-2-yl)oxy]piperidine-1-carboxylate
442199-08-8

t-butyl 4-[(pyrazin-2-yl)oxy]piperidine-1-carboxylate

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 2h;100%
In hexane; dimethyl sulfoxide; ethyl acetate
4-trifluoromethoxybenzyl bromide
50824-05-0

4-trifluoromethoxybenzyl bromide

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

4-[(4-trifluoromethoxy)phenyl]methoxypiperidine-1-formic acid tert-butyl ester
287952-21-0

4-[(4-trifluoromethoxy)phenyl]methoxypiperidine-1-formic acid tert-butyl ester

Conditions
ConditionsYield
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium t-butanolate In 1,2-dimethoxyethane at 2 - 17℃; for 0.5h;
Stage #2: 4-trifluoromethoxybenzyl bromide In 1,2-dimethoxyethane at 12 - 23℃; for 3h;
100%
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In N,N-dimethyl-formamide; mineral oil for 0.5h; Cooling with ice;
Stage #2: 4-trifluoromethoxybenzyl bromide In N,N-dimethyl-formamide; mineral oil at 20℃; for 15h; Cooling with ice;
78%
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In N,N-dimethyl-formamide; mineral oil for 0.5h; Cooling with ice;
Stage #2: 4-trifluoromethoxybenzyl bromide In N,N-dimethyl-formamide; mineral oil at 20℃; for 15h;
78%
chloroacetic acid pyrrolidide
20266-00-6

chloroacetic acid pyrrolidide

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-(2-oxo-2-(pyrrolidin-1-yl)ethoxy)piperidine-1-carboxylate
1174044-60-0

tert-butyl 4-(2-oxo-2-(pyrrolidin-1-yl)ethoxy)piperidine-1-carboxylate

Conditions
ConditionsYield
With trifluoroacetic acid; sodium hydroxide In water; toluene at 25℃;100%
4,6-dichloropyrimidine
1193-21-1

4,6-dichloropyrimidine

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-((6-chloropyrimidin-4-yl)oxy)piperidine-1-carboxylate
442199-19-1

tert-butyl 4-((6-chloropyrimidin-4-yl)oxy)piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In tetrahydrofuran; mineral oil at 60℃; for 1h;
Stage #2: 4,6-dichloropyrimidine In tetrahydrofuran; mineral oil at 20℃; for 2h;
100%
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In tetrahydrofuran at 60℃; for 1h; Inert atmosphere;
Stage #2: 4,6-dichloropyrimidine In tetrahydrofuran at 20℃; for 2h;
72%
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In tetrahydrofuran at 60℃; for 0.5h;
Stage #2: 4,6-dichloropyrimidine In tetrahydrofuran at 20℃;
59%
3-bromo-5-hydroxy-dipyrido[2,3-b;4',3'-d]pyrrole-9-carboxylic acid benzyl ester
1312756-30-1

3-bromo-5-hydroxy-dipyrido[2,3-b;4',3'-d]pyrrole-9-carboxylic acid benzyl ester

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

3-bromo-5-(1-tert-butoxycarbonyl-piperidin-4-yloxy)-dipyrido[2,3-b;4',3'-d]pyrrole-9-carboxylic acid benzyl ester
1312756-31-2

3-bromo-5-(1-tert-butoxycarbonyl-piperidin-4-yloxy)-dipyrido[2,3-b;4',3'-d]pyrrole-9-carboxylic acid benzyl ester

Conditions
ConditionsYield
With diethylazodicarboxylate; triphenylphosphine In tetrahydrofuran at 50℃; for 1h;100%
methyl 6-(2,6-difluoro-4-hydroxyphenyl)-5-fluoropyridine-2-carboxylate
1355011-30-1

methyl 6-(2,6-difluoro-4-hydroxyphenyl)-5-fluoropyridine-2-carboxylate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

methyl 6-(4-((1-(tert-butoxycarbonyl)piperidin-4-yl)oxy)-2,6-difluorophenyl)-5-fluoropicolinate
1395284-49-7

methyl 6-(4-((1-(tert-butoxycarbonyl)piperidin-4-yl)oxy)-2,6-difluorophenyl)-5-fluoropicolinate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃;100%
2-chloro-6-trifluoromethylpyridine
39890-95-4

2-chloro-6-trifluoromethylpyridine

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-{[6-(trifluoromethyl)pyridin-2-yl]oxy}piperidine-1-carboxylate

tert-butyl 4-{[6-(trifluoromethyl)pyridin-2-yl]oxy}piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In tetrahydrofuran; mineral oil at 20℃; for 1h;
Stage #2: 2-chloro-6-trifluoromethylpyridine In tetrahydrofuran; mineral oil at 20℃; for 48h;
100%
propargyl bromide
106-96-7

propargyl bromide

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-(prop-2-yn-1-yloxy)piperidine-1-carboxylate
1219827-56-1

tert-butyl 4-(prop-2-yn-1-yloxy)piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5h;
Stage #2: propargyl bromide In tetrahydrofuran; mineral oil at 25℃; for 12h;
100%
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5h; Inert atmosphere;
Stage #2: propargyl bromide In tetrahydrofuran; mineral oil at 25℃; for 12h; Inert atmosphere;
100%
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5h; Inert atmosphere;
Stage #2: propargyl bromide In tetrahydrofuran; mineral oil at 25℃; for 12h; Inert atmosphere;
100%
In tetrahydrofuran; toluene; mineral oil
N-[(5-chloro-2-ethylsulfonylphenyl)methyl]-4-hydroxy-3-(trifluoromethyl)benzamide

N-[(5-chloro-2-ethylsulfonylphenyl)methyl]-4-hydroxy-3-(trifluoromethyl)benzamide

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

4-[4-[(5-chloro-2-ethylsulfonylphenyl)methylcarbamoyl]-2-(trifluoromethyl)phenoxy]piperidine-1-carboxylic acid tert-butyl ester

4-[4-[(5-chloro-2-ethylsulfonylphenyl)methylcarbamoyl]-2-(trifluoromethyl)phenoxy]piperidine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20 - 50℃; for 19h;100%
2,5-dichloro-4-(trifluoromethyl)pyridine
89719-92-6

2,5-dichloro-4-(trifluoromethyl)pyridine

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-((5-chloro-4-(trifluoromethyl)pyridin-2-yl)oxy)piperidine-1-carboxylate

tert-butyl 4-((5-chloro-4-(trifluoromethyl)pyridin-2-yl)oxy)piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In 1,2-dimethoxyethane; mineral oil at 20℃; for 1h; Inert atmosphere;
Stage #2: 2,5-dichloro-4-(trifluoromethyl)pyridine In 1,2-dimethoxyethane; mineral oil for 2h; Inert atmosphere; Reflux;
100%
2-chloro-4-fluorobenzylbromide
45767-66-6

2-chloro-4-fluorobenzylbromide

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-((2-chloro-4-fluorobenzyl)oxy)piperidine-1-carboxylate

tert-butyl 4-((2-chloro-4-fluorobenzyl)oxy)piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 1h;
Stage #2: 2-chloro-4-fluorobenzylbromide With tetra-(n-butyl)ammonium iodide In N,N-dimethyl-formamide; mineral oil at 20℃; for 48h;
100%
5-bromo-2,3-dichloropyridine
97966-00-2

5-bromo-2,3-dichloropyridine

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-((5-bromo-3-chloropyridin-2-yl)oxy)piperidine-1-carboxylate

tert-butyl 4-((5-bromo-3-chloropyridin-2-yl)oxy)piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 1h;
Stage #2: 5-bromo-2,3-dichloropyridine In N,N-dimethyl-formamide; mineral oil at 70℃; for 16h;
100%
Stage #1: t-butyl 4-hydroxy piperidine-1-carboxylate With sodium hydride In N,N-dimethyl acetamide at 20℃; for 1h;
Stage #2: 5-bromo-2,3-dichloropyridine In N,N-dimethyl acetamide at 80℃; Inert atmosphere;
57%
methyl 4-hydroxy-2-methoxybenzoate
28478-46-8

methyl 4-hydroxy-2-methoxybenzoate

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

4-(N-t-Butoxycarbonyl-4-piperidinyloxy)-2-methoxybenzoic acid methyl ester
162045-37-6

4-(N-t-Butoxycarbonyl-4-piperidinyloxy)-2-methoxybenzoic acid methyl ester

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 40℃; for 2h; Inert atmosphere; Sonication;100%
2-hydroxyl nicotinic acid ethyl ester
27805-12-5

2-hydroxyl nicotinic acid ethyl ester

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

C18H26N2O5

C18H26N2O5

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 4h; Mitsunobu Displacement;100%
6-methoxypyridine-3-ol
51834-97-0

6-methoxypyridine-3-ol

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

tert-butyl 4-((6-methoxypyridin-3-yl)oxy)piperidine-1-carboxylate

tert-butyl 4-((6-methoxypyridin-3-yl)oxy)piperidine-1-carboxylate

Conditions
ConditionsYield
With triphenylphosphine In tetrahydrofuran at 20℃; for 9h; Inert atmosphere;100%
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 40℃; for 1h; Inert atmosphere;
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 40℃; for 1h; Inert atmosphere;
methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate
141699-59-4

1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate

Conditions
ConditionsYield
With triethylamine In dichloromethane; ethyl acetate100%
With triethylamine In dichloromethane; ethyl acetate100%
With triethylamine In dichloromethane; ethyl acetate100%

109384-19-2Relevant articles and documents

Synthesis of C-substituted cyclic amines using azacycloalkyl organozinc reagents

Billotte

, p. 379 - 380 (1998)

Azetidine and piperidine derived organozinc species have been prepared from the corresponding azacycloalkyl iodides by direct Zn insertion. They have been shown to readily undergo Pd(0) mediated cross-coupling reactions and to transmetallate with CuCN.2LiCl.

Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging

Effendi, Nurmaya,Mishiro, Kenji,Takarada, Takeshi,Yamada, Daisuke,Nishii, Ryuichi,Shiba, Kazuhiro,Kinuya, Seigo,Odani, Akira,Ogawa, Kazuma

, p. 383 - 393 (2019)

Several malignant tumors and fibrotic diseases are associated with PDGFRβ overexpression and excessive signaling, making this receptor attractive for molecular targeting and imaging approaches. A series of benzo[d]imidazole-quinoline derivatives were designed and synthesized to develop radioiodinated compounds as PDGFRβ-specific imaging probes. The structure activity relationship (SAR) evaluation of the designed compounds was performed. Among them, 2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]-8-(piperazin-1-yl)quinoline (5a) and 4-{2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]quinolin-8-yl}morpholine (5d) exhibited a relatively high PDGFRβ-TK inhibitory potency, whereas iodinated 5a derivative 5-iodo-2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]-8-(piperazin-1-yl)quinoline (8) exhibited a superior inhibitory potency as PDGFRβ inhibitor than iodinated 5d derivative 4-{5-iodo-2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]quinolin-8-yl}morpholine (11). Furthermore, [125I]8 and [125I]11 were synthesized and evaluated for PDGFRβ radioligand ability, both in vitro and in vivo. Cellular uptake experiments showed that [125I]8 had a higher uptake in BxPC3-luc cells as PDGFRβ-positive cells than [125I]11. Incubation of [125I]8 after pretreatment of PDGFRβ ligands significantly reduced the uptake of [125I]8. In biodistribution experiments using tumor-bearing mice, [125I]8 accumulation in the tumor 1 h postinjection was higher than that of the benzo[d]imidazol-quinoline derivative [125I]IIQP, used in our previous research. These results indicate that [125I]8 could be a promising PDGFRβ imaging agent. Although its clinical application requires further structural modifications, the results obtained in this research may be useful for the development of PDGFRβ-specific radioligands.

Hierarchically assembled helicates as reaction platform – from stoichiometric Diels–Alder reactions to enamine catalysis

Albrecht, Markus,Begall, Jenny,Craen, David Van,Gro?kurth, Johannes,Himmel, Leonard,Isaak, Elisabeth,Linnenberg, Oliver

, p. 2338 - 2345 (2020)

The stereoselectivity of a Diels–Alder reaction within the periphery of hierarchically assembled titanium(IV) helicates formed from mixtures of achiral, reactive and chiral, unreactive ligands was investigated in detail. Following the pathway of the chiral induction, the chiral ligands, solvents as well as substituents at the dienophile were carefully varied. Based on the results of the stoichiometric reaction, a secondary amine-catalyzed nitro-Michael reaction is performed as well which afforded reasonable diastereoselectivities.

Selective reduction of ketones using water as a hydrogen source under high hydrostatic pressure

Tomin, Anna,Lazarev, Alexander,Bere, Matthew P.,Redjeb, Hana,T?r?k, Béla

, p. 7321 - 7326 (2012)

A selective reduction of a broad variety of ketones is described. The method is based on the combination of a Ni-Al alloy and high hydrostatic pressure (HHP, 2.8 kbar) in an aqueous medium. The reaction of the Ni-Al alloy with water provides in situ hydrogen generation and the high pressure ensures that the H2 formed remains in the solution, thus the CO reduction readily occurs. The application of the HHP resulted in selective formation of the desired products and the common problem of non-selective overhydrogenation could be avoided. In most cases the reductions resulted in high yields and excellent selectivities without the use of any base.

Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against Gram-positive pathogens

Hirokawa, Yoshimi,Kinoshita, Hironori,Tanaka, Tomoyuki,Nakata, Katsuhisa,Kitadai, Noriyuki,Fujimoto, Koichi,Kashimoto, Shigeki,Kojima, Tsuyoshi,Kato, Shiro

, p. 1991 - 1994 (2008)

Although earlier pleuromutilin analogues showed potent in vitro antibacterial activity against some Gram-positive pathogens, their in vivo efficacy was low because of insufficient pharmacokinetic properties. We designed novel thioether pleuromutilin derivatives having a purine ring as a polar and water solubilizing group and identified a promising pleuromutilin analogue 6 with good solubility in water (~50 mg/mL). Compound 6 exhibited excellent in vitro and in vivo antibacterial activity against some Gram-positive strains, including drug-resistant pathogens.

The first radiosynthesis of [11C]AZD8931 as a new potential PET agent for imaging of EGFR, HER2 and HER3 signaling

Wang, Min,Gao, Mingzhang,Zheng, Qi-Huang

, p. 4455 - 4459 (2014)

The reference standard AZD8931{2-(4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-N-methylacetamide} (11a) was synthesized from methyl 4,5-dimethoxy-2-nitrobenzoate or ethyl 4,5-dimethoxy-2-nitrobenzoate and 2-chloro-N-methylacetamide in 11 steps with 2-5% overall chemical yield. The precursor N-desmethyl-AZD8931{2-(4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)acetamide} (11b) was synthesized from methyl 4,5-dimethoxy-2-nitrobenzoate or ethyl 4,5-dimethoxy-2-nitrobenzoate and 2-bromoacetamide in 11 steps with 2-4% overall chemical yield. The target tracer [11C]AZD8931 {2-(4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-N-[11C]methylacetamide} ([11C]11a) was prepared from N-desmethyl-AZD8931 (11b) with [11C]CH3OTf under basic condition (NaH) through N-[11C]methylation and isolated by HPLC combined with solid-phase extraction (SPE) in 40-50% radiochemical yield based on [11C]CO2and decay corrected to end of bombardment (EOB) with 370-1110 GBq/μmol specific activity at EOB.

Design, synthesis and biological evaluation of 2-substituted-6-[(4-substituted-1-piperidyl)methyl]-1H-benzimidazoles as inhibitors of ebola virus infection

Bessières, Maxime,Plebanek, El?bieta,Chatterjee, Payel,Shrivastava-Ranjan, Punya,Flint, Mike,Spiropoulou, Christina F.,Warszycki, Dawid,Bojarski, Andrzej J.,Roy, Vincent,Agrofoglio, Luigi A.

, (2021/02/06)

Novel 2-substituted-6-[(4-substituted-1-piperidyl)methyl]-1H-benzimidazoles were designed and synthesized as Ebola virus inhibitors. The proposed structures of the new prepared benzimidazole-piperidine hybrids were confirmed based on their spectral data and CHN analyses. The target compounds were screened in vitro for their anti-Ebola activity. Among tested molecules, compounds 26a (EC50=0.93 μM, SI = 10) and 25a (EC50=0.64 μM, SI = 20) were as potent as and more selective than Toremifene reference drug (EC50 = 0.38 μM, SI = 7) against cell line. Data suggests that the mechanism by which 25a and 26a block EBOV infection is through the inhibition of viral entry at the level of NPC1. Furthermore, a docking study revealed that several of the NPC1 amino acids that participate in binding to GP are involved in the binding of the most active compounds 25a and 26a. Finally, in silico ADME prediction indicates that 26a is an idealy drug-like candidate. Our results could enable the development of small molecule drug capable of inhibiting Ebola virus, especially at the viral entry step.

Sustainable Route Toward N-Boc Amines: AuCl3/CuI-Catalyzed N-tert-butyloxycarbonylation of Amines at Room Temperature

Cao, Yanwei,He, Lin,Huang, Yang

, (2021/12/22)

N-tert-butoxycarbonyl (N-Boc) amines are useful intermediates in synthetic/medicinal chemistry. Traditionally, they are prepared via an indirect phosgene route with poor atom economy. Herein, a step- and atom-economic synthesis of N-Boc amines from amines, t-butanol, and CO was reported at room temperature. Notably, this N-tert-butyloxycarbonylation procedure utilized ready-made substrates, commercially available AuCl3/CuI as catalysts, and O2 from air as the sole oxidant. This catalytic system provided unique selectivity for N-Boc amines in good yields. More significantly, gram-scale preparation of medicinally important N-Boc amine intermediates was successfully implement, which demonstrated a potential application prospect in industrial syntheses. Furthermore, this approach also showed good compatibility with tertiary and other useful alcohols. Investigations of the mechanisms revealed that gold catalyzed the reaction and copper acted as electron transfer mediator in the catalytic cycle.

NOVEL ARYLOXYPIPERIDINE PYRAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS

-

Page/Page column 103, (2020/03/15)

Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 109384-19-2